US$ 26.10
do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Clinical Use of do not combine dpp-4 inhibitors
Description
Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report

Shivani Patel, Research Scientist
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting
doi:10.1007/s12264-018-00336-7 192

Oral drugs do away with several of the drawbacks that are associated with injectable drugs, such as needle fear and difficulties with administration

doi: 10.2337/dc15-2727 277 HardingJJGaneaE
